Citigroup’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Citigroup’s Portfolio SBIO Stock Details SBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1	Closed	-$52	–	6177
2026 Q1	$52	Hold	1	–	–	﹤0.01%	5642
2025 Q4	$51	Sell	1 -44	-98%	-$2.04K	﹤0.01%	5703
2025 Q3	$1.75K	Buy	+45	New	+$1.55K	﹤0.01%	5514
2020 Q1	–	Sell	-70	Closed	-$3K	–	7756
2019 Q4	$3K	Buy	+70	New	+$2.6K	﹤0.01%	7500
2019 Q3	–	Sell	-500	Closed	-$18K	–	7802
2019 Q2	$18K	Hold	500	–	–	﹤0.01%	7129
2019 Q1	$18K	Sell	500 -300	-38%	-$10K	﹤0.01%	7015
2018 Q4	$23K	Sell	800 -700	-47%	-$23.2K	﹤0.01%	6813
2018 Q3	$59K	Hold	1,500	–	–	﹤0.01%	6381
2018 Q2	$56K	Hold	1,500	–	–	﹤0.01%	6205
2018 Q1	$51K	Sell	1,500 -405	-21%	-$14.2K	﹤0.01%	6158
2017 Q4	$62K	Hold	1,905	–	–	﹤0.01%	6026
2017 Q3	$59K	Hold	1,905	–	–	﹤0.01%	5910
2017 Q2	$53K	Hold	1,905	–	–	﹤0.01%	5746
2017 Q1	$49K	Buy	1,905 +815	+75%	+$20.3K	﹤0.01%	5715
2016 Q4	$25K	Buy	1,090 +200	+22%	+$4.79K	﹤0.01%	6447
2016 Q3	$23K	Buy	+890	New	+$22.2K	﹤0.01%	6134
2016 Q1	–	Sell	-100	Closed	-$3K	–	7725
2015 Q4	$3K	Buy	+100	New	+$3.06K	﹤0.01%	7198

Other funds holding SBIO

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

CIS

Connors Investor Services Wyomissing, Pennsylvania $1.16B AUM 27.24% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

MWM

Moran Wealth Management Naples, Florida $3.67B AUM 36.71% 1-Year Est. Return

GAM

Griffin Asset Management New York $949M AUM 24.98% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return

Citigroup's SBIO Position: Q2 2026 in Review

Citigroup sold out of ALPS Medical Breakthroughs ETF (SBIO) in Q2 2026, closing a stake of 1 share — an estimated $52 sold.

Citigroup first reported a position in SBIO in Q4 2015 and held it in 17 quarters. The position peaked at $62K in Q4 2017. 66 funds tracked by Wall St. Rank hold SBIO as of Q2 2026.

Citigroup reported no remaining ALPS Medical Breakthroughs ETF position as of Q2 2026 after selling out during the quarter.
Citigroup sold 1 ALPS Medical Breakthroughs ETF share in Q2 2026, an estimated $52.
Citigroup first reported a position in ALPS Medical Breakthroughs ETF in Q4 2015 and held it in 17 quarters.
Citigroup's ALPS Medical Breakthroughs ETF position peaked at $62K in Q4 2017.
66 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.